Stay updated with breaking news from Tim Dyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Addex receives CHF5M and 20% share of Neurosterix Perceptive Advisors leads $63M investment into Neurosterix Addex contributes portfolio of...
Addex receives CHF5M and 20% share of Neurosterix Perceptive Advisors leads $63M investment into Neurosterix Addex contributes portfolio of preclinical neuroscience assets and...
(RTTNews) - Addex Therapeutics (ADXN) and funds affiliated with Perceptive Advisors announced the launch of Neurosterix, a company focused on deve...